Search

Mansour Oveissi

Examiner (ID: 18658, Phone: (571)270-3127 , Office: P/2415 )

Most Active Art Unit
2415
Art Unit(s)
2616, 2464, 2415, 2416
Total Applications
1005
Issued Applications
795
Pending Applications
89
Abandoned Applications
156

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17910378 [patent_doc_number] => 20220312772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => MICROBIAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/625451 [patent_app_country] => US [patent_app_date] => 2020-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -77 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625451 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625451
MICROBIAL COMPOSITIONS Jul 9, 2020 Pending
Array ( [id] => 17168712 [patent_doc_number] => 20210322382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF SINUS DISEASE [patent_app_type] => utility [patent_app_number] => 16/892218 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8387 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892218 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/892218
METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF SINUS DISEASE Jun 2, 2020 Abandoned
Array ( [id] => 20212038 [patent_doc_number] => 12408668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Stable microbicide composition [patent_app_type] => utility [patent_app_number] => 17/615694 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1088 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615694 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/615694
Stable microbicide composition Jun 1, 2020 Issued
Array ( [id] => 20212038 [patent_doc_number] => 12408668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Stable microbicide composition [patent_app_type] => utility [patent_app_number] => 17/615694 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1088 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615694 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/615694
Stable microbicide composition Jun 1, 2020 Issued
Array ( [id] => 18232090 [patent_doc_number] => 11596634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-07 [patent_title] => Lamotrigine oral liquid suspension and use thereof [patent_app_type] => utility [patent_app_number] => 15/929929 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10084 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15929929 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/929929
Lamotrigine oral liquid suspension and use thereof May 28, 2020 Issued
Array ( [id] => 20076247 [patent_doc_number] => 12350281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-08 [patent_title] => Long-acting injectable formulations and use thereof [patent_app_type] => utility [patent_app_number] => 16/879626 [patent_app_country] => US [patent_app_date] => 2020-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4908 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879626 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/879626
Long-acting injectable formulations and use thereof May 19, 2020 Issued
Array ( [id] => 18127907 [patent_doc_number] => 11554102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-17 [patent_title] => Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders [patent_app_type] => utility [patent_app_number] => 15/930295 [patent_app_country] => US [patent_app_date] => 2020-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17150 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930295 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/930295
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders May 11, 2020 Issued
Array ( [id] => 18947068 [patent_doc_number] => 11890341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-06 [patent_title] => Compositions and methods for treating biofilm-related lung conditions [patent_app_type] => utility [patent_app_number] => 16/871504 [patent_app_country] => US [patent_app_date] => 2020-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9945 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871504 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/871504
Compositions and methods for treating biofilm-related lung conditions May 10, 2020 Issued
Array ( [id] => 18013288 [patent_doc_number] => 11505570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Organic acid salt of nicotinamide riboside, composition including organic acid salt, and preparation methods of organic acid salt and composition [patent_app_type] => utility [patent_app_number] => 17/595192 [patent_app_country] => US [patent_app_date] => 2020-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4455 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595192 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595192
Organic acid salt of nicotinamide riboside, composition including organic acid salt, and preparation methods of organic acid salt and composition May 10, 2020 Issued
Array ( [id] => 17718321 [patent_doc_number] => 20220211040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => HIGH SPREADING ULV FORMULATIONS FOR INSECTICIDES [patent_app_type] => utility [patent_app_number] => 17/595082 [patent_app_country] => US [patent_app_date] => 2020-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15635 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595082 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595082
HIGH SPREADING ULV FORMULATIONS FOR INSECTICIDES May 7, 2020 Pending
Array ( [id] => 17422391 [patent_doc_number] => 11255838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => Levels, functions, and resistances related to chronic conditions by using lysine-based supplements [patent_app_type] => utility [patent_app_number] => 16/865064 [patent_app_country] => US [patent_app_date] => 2020-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11436 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865064 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/865064
Levels, functions, and resistances related to chronic conditions by using lysine-based supplements Apr 30, 2020 Issued
Array ( [id] => 16420607 [patent_doc_number] => 20200345805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE [patent_app_type] => utility [patent_app_number] => 16/854818 [patent_app_country] => US [patent_app_date] => 2020-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4842 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854818 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/854818
COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE Apr 20, 2020 Abandoned
Array ( [id] => 16504672 [patent_doc_number] => 20200383928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD [patent_app_type] => utility [patent_app_number] => 16/845184 [patent_app_country] => US [patent_app_date] => 2020-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845184 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/845184
Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method Apr 9, 2020 Issued
Array ( [id] => 16174736 [patent_doc_number] => 20200221704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => METHOD FOR PRODUCING A PLANT LIFE ENHANCING PRODUCT [patent_app_type] => utility [patent_app_number] => 16/833695 [patent_app_country] => US [patent_app_date] => 2020-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13626 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833695 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/833695
METHOD FOR PRODUCING A PLANT LIFE ENHANCING PRODUCT Mar 29, 2020 Abandoned
Array ( [id] => 18353967 [patent_doc_number] => 11642351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-09 [patent_title] => Eslicarbazepine suspension [patent_app_type] => utility [patent_app_number] => 16/827534 [patent_app_country] => US [patent_app_date] => 2020-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6978 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827534 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/827534
Eslicarbazepine suspension Mar 22, 2020 Issued
Array ( [id] => 18792695 [patent_doc_number] => 11826429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-28 [patent_title] => Pharmaceutical composition comprising brinzolamide [patent_app_type] => utility [patent_app_number] => 16/811674 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 9655 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811674 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/811674
Pharmaceutical composition comprising brinzolamide Mar 5, 2020 Issued
Array ( [id] => 16086847 [patent_doc_number] => 20200197410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => D2O STABILIZED PHARMACEUTICAL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/805612 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805612 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/805612
D2O stabilized pharmaceutical formulations Feb 27, 2020 Issued
Array ( [id] => 16266486 [patent_doc_number] => 20200267973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => ALKALINE DISINFECTING COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/796990 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7898 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796990 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/796990
ALKALINE DISINFECTING COMPOSITIONS Feb 20, 2020 Pending
Array ( [id] => 20385425 [patent_doc_number] => 12485134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-02 [patent_title] => Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations [patent_app_type] => utility [patent_app_number] => 16/798207 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 30 [patent_no_of_words] => 27281 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798207 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/798207
Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations Feb 20, 2020 Issued
Array ( [id] => 16435578 [patent_doc_number] => 20200352903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => Choline Esters [patent_app_type] => utility [patent_app_number] => 16/791265 [patent_app_country] => US [patent_app_date] => 2020-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791265 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/791265
Choline Esters Feb 13, 2020 Abandoned
Menu